Drugs News and Research

RSS

WSU collaborates with Botanisol to study and develop new anti-inflammatory drug

Work on a new anti-inflammatory drug developed from the medicinal/spice plant turmeric recently received funding from a $225,000 grant from the National Institutes of Health National Center for Complementary and Integrative Health.

28 Oct 2015

Oral formulation of insulin shows promise in management of blood glucose in diabetic rats

An intestinal patch device containing insulin that can be swallowed in the form of a capsule, in development by researchers at University of California Santa Barbara, has demonstrated efficacy of blood glucose management in diabetic rats. This work is being presented Oct. 27 at the 2015 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Orlando, Fla. Oct. 25-29.

28 Oct 2015

Imlygic approved for treatment of melanoma lesions in the skin and lymph nodes

The U.S. Food and Drug Administration today approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the skin and lymph nodes.

28 Oct 2015

Study uncovers new genetic variants linked to increased risk of testicular cancer

A new study of more than 25,000 men has uncovered four new genetic variants associated with increased risk of testicular cancer.

27 Oct 2015

Love hormone may enhance pleasure of social interactions, UCI study finds

The hormone oxytocin, which has been associated with interpersonal bonding, may enhance the pleasure of social interactions by stimulating production of marijuana-like neurotransmitters in the brain, according to a University of California, Irvine study.

27 Oct 2015

Targeting invasive cells could be a new strategy to treat metastatic cancer, say Stony Brook researchers

Most cancer drugs are designed to target dividing cells, but a new study by Stony Brook University researchers suggests that targeting invasive cells may be a new strategy to treat metastatic cancer.

27 Oct 2015

New computer model predicts levels of HIV care engagement

A computer model developed by Johns Hopkins health care delivery specialists predicts that strengthening a handful of efforts to keep people with HIV in lifetime care, along with more rigorous testing, would potentially avert a projected 752,000 new HIV infections and 276,000 AIDS deaths in the United States alone over the next 20 years.

27 Oct 2015

Discovery may open new doors to understanding how melanoma grows and spreads

Of the hundreds of genes that can be mutated in a single case of melanoma, only a handful may be true "drivers" of cancer. In research that recently appeared in Nature Genetics, a Weizmann Institute of Science team has now revealed one of the drivers of a particularly deadly subset of melanomas that is seeing a rise in new cases.

27 Oct 2015

Brief exposure to general anesthesia during infancy does not affect neurological development

Although the medical community has raised concerns about the safety of anesthesia on the developing brains of young children, new research presented at the ANESTHESIOLOGY 2015 annual meeting, found brief exposure to general anesthesia during infancy did not impair neurological development. This is the first prospective, randomized, controlled clinical trial to assess the long-term, neurological effects of anesthesia in children.

27 Oct 2015

U-M study suggests new therapeutic strategy for treating Duchene muscular dystrophy

Every heart beat and step in our daily lives is dependent on the integrity of muscles and the proteins that keep them strong and free of injury as they contract and relax.

27 Oct 2015

New study identifies molecular mechanism that prevents immunotherapy drugs from killing off cancer

Immunotherapy treatments have proven wildly successful in treating some patients with cancer. But despite this success, the majority of patients do not respond to the treatments.

27 Oct 2015

Unique, tiny protein cage developed to deliver chemotherapy chemicals directly to cancer cells

Washington State University researchers have developed a unique, tiny protein cage to deliver nasty chemotherapy chemicals directly to cancer cells. Direct delivery could improve treatment and lessen what can be horrendous side effects from toxic drugs.

27 Oct 2015

Researchers pinpoint mechanisms that cause chemoresistance in ovarian cancer patients

Resistance to chemotherapy is a major problem for those suffering from ovarian cancer--a problem that prevents a cure from a disease dubbed the "silent killer." University of Georgia researchers are giving patients new hope with recent findings that help pinpoint the mechanisms causing chemoresistance.

27 Oct 2015

Genetic discovery sheds light on how prostate cancer develops and spreads

A new and important genetic discovery, which sheds light on how prostate cancers develop and spread, has been made by an international research team led by scientists at The University of Nottingham.

27 Oct 2015

Expectant mothers need to avoid certain cosmetics, cleaning agents and medicines during first trimester

Expectant mothers in their first trimester should avoid certain cosmetics, cleaning agents and medicines, to protect the developing fetal brain from chemicals that can trigger autism, York U health researchers have found.

27 Oct 2015

New drug combination may be effective against malignant melanoma

A team of Massachusetts General Hospital investigators has discovered a new combination of drugs that may be effective against one of the deadliest cancers, malignant melanoma. The combination - pairing a drug targeted against mutations in the BRAF gene with a second drug that targets another important signaling pathway - was discovered through one of the largest screens of cancer drug combinations conducted to date.

27 Oct 2015

Ipsen, EpiVax partner to create next generation botulinum neurotoxin and TSI therapeutics

Ipsen and the US company EpiVax, Inc. today announced that they have completed a collaborative project that provides a novel approach for creating next generation botulinum neurotoxin (BoNT) and Targeted Secretion Inhibitor (TSI) therapeutics.

27 Oct 2015

Nanofiber hydrogel infused with snake venom may stop bleeding, protect wounds

A nanofiber hydrogel infused with snake venom may be the best material to stop bleeding quickly, according to Rice University scientists.

27 Oct 2015

Mast Therapeutics begins vepoloxamer Phase 2 study in patients with chronic heart failure

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging its molecular adhesion and sealant technology (MAST) platform to develop novel therapies for sickle cell disease, heart failure, and stroke, announced that it has initiated its Phase 2 study of vepoloxamer for the treatment of patients with chronic heart failure.

26 Oct 2015

Study: Pediatric patients prescribed more opioid medication than necessary following surgery

Although it is not uncommon for pediatric patients to be prescribed opioids to treat certain types of moderate to severe pain, new research suggests these patients may be prescribed more opioids than necessary following surgery. A study presented at the ANESTHESIOLOGY 2015 annual meeting found nearly 60 percent of opioids dispensed to pediatric patients following surgery remained unused, which could lead to the unused medication being abused by other adolescents in the household.

26 Oct 2015

Drugs News and Research

WSU collaborates with Botanisol to study and develop new anti-inflammatory drug

Oral formulation of insulin shows promise in management of blood glucose in diabetic rats

Imlygic approved for treatment of melanoma lesions in the skin and lymph nodes

Study uncovers new genetic variants linked to increased risk of testicular cancer

Love hormone may enhance pleasure of social interactions, UCI study finds

Targeting invasive cells could be a new strategy to treat metastatic cancer, say Stony Brook researchers

New computer model predicts levels of HIV care engagement

Discovery may open new doors to understanding how melanoma grows and spreads

Brief exposure to general anesthesia during infancy does not affect neurological development

U-M study suggests new therapeutic strategy for treating Duchene muscular dystrophy

New study identifies molecular mechanism that prevents immunotherapy drugs from killing off cancer

Unique, tiny protein cage developed to deliver chemotherapy chemicals directly to cancer cells

Researchers pinpoint mechanisms that cause chemoresistance in ovarian cancer patients

Genetic discovery sheds light on how prostate cancer develops and spreads

Expectant mothers need to avoid certain cosmetics, cleaning agents and medicines during first trimester

New drug combination may be effective against malignant melanoma

Ipsen, EpiVax partner to create next generation botulinum neurotoxin and TSI therapeutics

Nanofiber hydrogel infused with snake venom may stop bleeding, protect wounds

Mast Therapeutics begins vepoloxamer Phase 2 study in patients with chronic heart failure

Study: Pediatric patients prescribed more opioid medication than necessary following surgery

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News